[ Price : $8.95]
Roche moves prasinezumab into a Phase 3 trial after two mid‑stage trials and their open‑label extensions hinted at a d...[ Price : $8.95]
Milestone Pharmaceuticals submits its response to a March-issued FDA complete response letter on the companys NDA for irregular he...[ Price : $8.95]
Zyno Medical recalls certain Z-800 infusion pumps because they were released to customers with incorrect software versions.[ Price : $8.95]
Qalitex Laboratories issues an alert to dietary supplement and wellness product sellers on Amazon about a growing overlap between ...[ Price : $8.95]
An AbbVie Phase 3 (VERONA) clinical trial evaluating venetoclax in combination with azacitidine for newly diagnosed higher-risk my...[ Price : $8.95]
Nipro recalls its MedicaLyte liquid bicarbonate concentrate after confirming bacterial and fungal contamination in returned produc...[ Price : $8.95]
FDA delays a review decision on a KalVista Pharmaceuticals NDA for sebetralstat, indicated for treating hereditary angioedema.[ Price : $8.95]
FDA approves Mercks Keytruda (pembrolizumab) as the first anti‑PD‑1 therapy that can be given both before and after su...